PXMD

PaxMedica Inc

1.4299
-0.0101 (-0.7%)
Company Name Stock Ticker Symbol Market Type
PaxMedica Inc PXMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0101 -0.7% 1.4299 19:53:23
Open Price Low Price High Price Close Price Prev Close
1.42 1.4194 1.4721 1.44 1.44
more quote information »

Recent News

Date Time Source Heading
5/15/202317:14EDGARQuarterly Report (10-q)
5/15/202317:06EDGARCurrent Report Filing (8-k)
5/15/202316:13GLOBEPaxMedica, Inc. Provides First Quarter 2023 Business Update;..
5/12/202306:05EDGARNotice of Effectiveness (effect)
5/11/202317:27EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/01/202319:53EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
5/01/202319:52EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
4/28/202316:12EDGARStatement of Changes in Beneficial Ownership (4)
4/28/202316:11EDGARStatement of Changes in Beneficial Ownership (4)
4/24/202316:49EDGARRevised Proxy Soliciting Materials (definitive) (defr14a)
4/19/202308:30GLOBEPaxMedica Announces NASDAQ Closing Bell Ringing to Celebrate..
4/14/202319:13EDGARStatement of Changes in Beneficial Ownership (4)
4/14/202319:13EDGARStatement of Changes in Beneficial Ownership (4)
4/14/202319:13EDGARStatement of Changes in Beneficial Ownership (4)
4/14/202319:12EDGARStatement of Changes in Beneficial Ownership (4)
4/14/202319:12EDGARStatement of Changes in Beneficial Ownership (4)
4/14/202319:11EDGARStatement of Changes in Beneficial Ownership (4)
4/14/202319:11EDGARStatement of Changes in Beneficial Ownership (4)
4/07/202316:14EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
4/05/202306:02EDGARPost-effective Amendment to Registration Statement (pos Am)
4/05/202306:01EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/31/202316:54EDGARProxy Statement - Notice of Shareholders Meeting..
3/30/202306:05EDGARAnnual Report (10-k)
3/30/202306:04EDGARCurrent Report Filing (8-k)
3/29/202319:21GLOBEPaxMedica, Inc. Provides Business Update and Reports Fourth..
3/20/202308:00GLOBEPaxMedica Holds Meeting of Scientific Advisory Board
2/15/202317:19EDGARCurrent Report Filing (8-k)
2/15/202307:30GLOBEPaxMedica Releases 2022 Shareholder Letter
2/07/202308:09EDGARCurrent Report Filing (8-k)
2/03/202308:00GLOBEPaxMedica, Inc. Secures $3.2 Million Growth Capital From..
1/20/202313:31GLOBEPaxMedica to Present at the Jan 26th Virtual Investor Summit..
1/06/202316:17EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/06/202316:14EDGARCurrent Report Filing (8-k)
12/28/202206:03EDGARNotice of Effectiveness (effect)
12/19/202216:31EDGARSecurities Registration Statement (s-1)
12/19/202216:17EDGARCurrent Report Filing (8-k)
12/14/202208:00GLOBEPaxMedica, Inc. Launches Updated Corporate Website at..
12/09/202216:11EDGARCurrent Report Filing (8-k)
11/22/202216:11EDGARStatement of Changes in Beneficial Ownership (4)
11/22/202208:00GLOBEPaxMedica to Present at the Benchmark Company’s Upcoming..
11/21/202217:07EDGARCurrent Report Filing (8-k)
11/18/202207:50TRMNPaxMedica Soars on Equity Deal with Lincoln Park Capital
11/17/202220:29GLOBEPaxMedica, Inc. Enters Into Committed Equity Investment..
11/15/202208:00GLOBEPaxMedica, Inc. Provides Business Update and Reports Third..
11/14/202216:55EDGARQuarterly Report (10-q)
11/08/202208:53EDGARCurrent Report Filing (8-k)
11/08/202208:00GLOBEPaxMedica Initiates Clinical Program to Advance PAX-101..
10/24/202208:00GLOBEPaxMedica Appoints Stefan Schwabe MD, PhD as Chief Medical..
10/12/202208:01EDGARCurrent Report Filing (8-k)
10/04/202217:27EDGARStatement of Changes in Beneficial Ownership (4)